Analyst Research

Analyst Sights on Price Reaction History: Tenet Healthcare Corp (NYSE:THC)

Tenet Healthcare Corp (NYSE:THC) shares traded 21.56% during the most recent session the stock exchanged hands 16.93M shares versus average trading capacity of 3.83M shares, yielding a market cap of $1.83B. Wall Street analysts covering the stock are projecting that the stock will reach $22.60 within the next 52-weeks. The mean target projections are based on 15 opinions, the mean target was last revised on 04/28/17.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Tenet Healthcare Corp (NYSE:THC) high price target of $28.00 and with a conservative view have low price target of $17.00 with a standard deviation of $5.80. If seeing target price from optimistic overview then it has a 50 percent upside potential from the latest closing price of $18.66.

Tenet Healthcare Corp (NYSE:THC) “Initiated” by Deutsche Bank in a research note issued to investors on Apr-05-17 as Buyat $28.

Additionally on Mar-27-17 Tenet Healthcare Corp (NYSE:THC) was “Reiterated” by Mizuho as Neutral from $22.50 to $18 and on Feb-24-17 the stock was “Upgraded” by Mizuho from Underperform to Neutral from $13 to $22.80. Furthermore on Jan-04-17 the stock was “Initiated” by Piper Jaffray as Neutral.

On the other hand the company has Relative Strength Index (RSI 14) of 61.55 along with Average True Range (ATR 14) of 0.92, Consequently Tenet Healthcare Corp (NYSE:THC) weekly and monthly volatility is 5.50%, 4.23% respectively. The company’s beta value is at 1.37.

In terms of Buy, Sell or Hold recommendations, Tenet Healthcare Corp (NYSE:THC) has analysts’ mean recommendation of 2.60. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

Analysts who have weighed in on projected earnings growth are expecting that Tenet Healthcare Corp (NYSE:THC)’s high EPS estimates are $0.57 and low estimates are -$.0.44 for the current quarter. However the company reported $0.38 earnings per share for the same quarter during last year.

Previously Tenet Healthcare Corp (NYSE:THC) reported -$0.27 earnings per share (EPS) for the quarter on 5/1/2017 After Market Close, beating the consensus estimate of -$0.53 by $0.26. The company posted an earnings surprise of 49.06%.

While considering growth estimates of the company, it has next quarter growth estimates of -31.20% whereas during current quarter it has -100.00% estimations over growth, comparing to the estimations of 12.50% during current year and 49.60% for next year. Past 5 years growth of Tenet Healthcare Corp (NYSE:THC) observed at -13.75%, looking forward for the next 5 years it has a strong prediction of 13.52% over growth.

Tenet Healthcare Corp (NYSE:THC) revenue estimates for the current quarter are $4.89B according to 16 number of analysts, for the current quarter the company has high revenue estimates of $4.99B in contradiction of low revenue estimates of $4.81B. For the current year the company’s revenue estimates are $19.82B compared to low analyst estimates of $19.6B and high estimates of $19.95B according 17 number of analysts.

Currently Tenet Healthcare Corp (NYSE:THC) shares owned by insiders are 1.60%. However the six-month change in the insider ownership was recorded 1.28%, as well as three-month change in the institutional ownership was recorded 4.53%.

Tenet Healthcare Corp (NYSE:THC) trading -44.12% away from its 52 week high of $33.39 and +32.72% far from the stock’s low point over the past 52 weeks, which was $14.06. The stock hit its 52-week high on 05/04/16, and 52-week low on 11/11/16. The company’s trailing twelve month income is -187.00M dollars.

Tenet Healthcare Corp (NYSE:THC) trailing twelve month revenues are $19.62B, whereas its price to sales ratio for the same period is 0.09. Its book value per share for the most recent quarter is $4.18 while its price to book ratio for the same period is 4.46, as for as the company’s cash per share for the most recent quarter is $7.23, however its price to cash per share ratio for the same period is 2.58. The stock has a current PEG ratio of 1.18 where as its trailing twelve month P/E ratio is -9.65.

Previous ArticleNext Article
%d bloggers like this: